2023 - Research.com Medicine in France Leader Award
2023 - Research.com Neuroscience in France Leader Award
2022 - Research.com Best Scientist Award
2022 - Research.com Medicine in France Leader Award
2022 - Research.com Neuroscience in France Leader Award
2001 - Grand prix de l'Inserm - Institut national de la santé et de la recherche médicale
Parkinson's disease, Internal medicine, Neuroscience, Endocrinology and Substantia nigra are his primary areas of study. Yves Agid interconnects Physical therapy, Dopamine and Degenerative disease in the investigation of issues within Parkinson's disease. His work on Cardiology expands to the thematically related Internal medicine.
His Neuroscience research is multidisciplinary, incorporating perspectives in Alzheimer's disease and Progressive supranuclear palsy. Many of his studies on Endocrinology apply to Lesion as well. His work carried out in the field of Substantia nigra brings together such families of science as Anatomy, Human brain and Midbrain.
Yves Agid focuses on Internal medicine, Endocrinology, Neuroscience, Parkinson's disease and Substantia nigra. His Endocrinology study frequently draws parallels with other fields, such as Human brain. Neuroscience is frequently linked to Progressive supranuclear palsy in his study.
His studies in Parkinson's disease integrate themes in fields like Central nervous system disease and Degenerative disease. His Degenerative disease study combines topics from a wide range of disciplines, such as Genetics and Parkinsonism. He combines subjects such as Ventral tegmental area, Anatomy and Midbrain with his study of Substantia nigra.
His primary areas of study are Parkinson's disease, Deep brain stimulation, Subthalamic nucleus, Neuroscience and Stimulation. His biological study spans a wide range of topics, including Physical therapy, Neurology, Physical medicine and rehabilitation and Degenerative disease. His Deep brain stimulation study integrates concerns from other disciplines, such as Dystonia and Globus pallidus.
His research investigates the connection with Stimulation and areas like Anesthesia which intersect with concerns in Central nervous system disease, Confidence interval and Cohort. His Levodopa research is under the purview of Internal medicine. As a part of the same scientific study, he usually deals with the Internal medicine, concentrating on Pathology and frequently concerns with Gastroenterology.
Yves Agid mainly focuses on Subthalamic nucleus, Anesthesia, Physical therapy, Parkinson's disease and Deep brain stimulation. His Anesthesia research includes elements of Progressive supranuclear palsy, Central nervous system disease, Excessive daytime sleepiness, Sleep onset and Polysomnography. Yves Agid has included themes like Bioinformatics and Degenerative disease in his Parkinson's disease study.
In his work, Anatomy is strongly intertwined with Substantia nigra, which is a subfield of Brain mapping. His research in Stimulation intersects with topics in Basal ganglia and Dopamine. To a larger extent, he studies Internal medicine with the aim of understanding Neurostimulation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) Report of the NINDS-SPSP International Workshop*
I. Litvan;Y. Agid;D. Calne;G. Campbell.
The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.
P. Damier;E. C. Hirsch;Y. Agid;A. M. Graybiel.
Association between Early-Onset Parkinson's Disease and Mutations in the Parkin Gene
CB Lucking;A Durr;Bonifati;J Vaughan.
The New England Journal of Medicine (2000)
Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease
D. T. Dexter;C. J. Carter;F. R. Wells;F. Javoy-Agid.
Journal of Neurochemistry (1989)
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
Etienne Hirsch;Ann M. Graybiel;Yves A. Agid.
Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease
D T Dexter;F R Wells;A J Lees;F Agid.
Journal of Neurochemistry (1989)
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia
Jeswinder Sian;D. T. Dexter;A. J. Lees;S. Daniel.
Annals of Neurology (1994)
Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
D. T. Dexter;A. Carayon;F. Javoy-Agid;Y. Agid.
Increased nigral iron content in postmortem parkinsonian brain.
D.T. Dexter;F.R. Wells;F. Agid;Y. Agid.
The Lancet (1987)
Neurostimulation for Parkinson's Disease with Early Motor Complications
W. M. M. Schuepbach;J. Rau;K. Knudsen;J. Volkmann.
The New England Journal of Medicine (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: